CADL
Candel Therapeutics, Inc.Company with tickers: CADL
CIK
1841387
CUSIP
137404109
Shares Outstanding
73,270,239
13F Activity (30d)
100 filings
98 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-31 | Manning Paul B |
10% Owner | Award | 4,618 |
| 2026-03-31 | Loggia Nicoletta |
Director | Award | 779 |
| 2026-03-31 | PAPA JOSEPH C |
Director, President and CEO | Award | 2,795 |
| 2026-02-23 | Manning Paul B |
10% Owner | Other | 1,681,000 |
| 2026-02-23 | Manning Paul B |
10% Owner | Other | 1,303,752 |
| 2026-02-23 | Manning Paul B |
10% Owner | Buy | 550,458 |
| 2026-01-26 | Schoch Charles |
Chief Financial Officer | Award | 232,000 |
| 2026-01-26 | Barone Francesca |
Chief Scientific Officer | Award | 232,000 |
| 2026-01-26 | Nichols William Garrett |
Chief Medical Officer | Award | 136,500 |
| 2026-01-26 | Tyagarajan Seshu |
Chief Technology Officer | Award | 154,000 |
| 2026-01-26 | Tak Paul Peter |
Director, Chief Executive Officer | Award | 629,000 |
| 2025-07-28 | Nichols William Garrett |
Chief Medical Officer | Convert | 937 |
| 2025-07-28 | Nichols William Garrett |
Chief Medical Officer | Sell | 937 |
| 2025-07-28 | Nichols William Garrett |
Chief Medical Officer | Convert | 937 |
| 2025-06-30 | Nichols William Garrett |
Chief Medical Officer | Convert | 781 |
| 2025-06-30 | Nichols William Garrett |
Chief Medical Officer | Convert | 781 |
| 2025-06-30 | Nichols William Garrett |
Chief Medical Officer | Sell | 781 |
| 2025-06-25 | Martell Christopher |
Director | Other | 152,000 |
| 2025-06-25 | Manning Paul B |
10% Owner | Award | 1,070,663 |
| 2025-06-25 | Martell Christopher |
Director | Award | 111,349 |
| 2025-06-25 | Nabel Gary J. |
Director, Chief Innovation Officer | Award | 5,353 |
| 2025-06-25 | Martell Christopher |
Director | Other | 283,514 |
| 2025-06-25 | Tyagarajan Seshu |
Chief Technology Officer | Award | 5,353 |
| 2025-06-25 | Schoch Charles |
Chief Financial Officer | Award | 5,353 |
| 2025-06-25 | Manning Paul B |
10% Owner | Other | 1,303,752 |
| 2025-06-25 | PAPA JOSEPH C |
Director, President and CEO | Award | 64,239 |
| 2025-06-25 | Manning Paul B |
10% Owner | Other | 1,681,000 |
| 2025-06-25 | Loggia Nicoletta |
Director | Award | 2,141 |
| 2025-06-25 | Barone Francesca |
Chief Scientific Officer | Award | 4,282 |
| 2025-06-25 | Tak Paul Peter |
Director, Chief Executive Officer | Award | 42,826 |
| 2025-06-25 | PAPA JOSEPH C |
Director, President and CEO | Other | 38,032 |
| 2025-06-20 | Schoch Charles |
Chief Financial Officer | Award | 50,000 |
| 2025-06-17 | Gaeta Renee |
Chief Financial Officer | Award | 14,240 |
| 2025-06-17 | Benz Edward J. JR |
Director | Award | 14,240 |
| 2025-06-17 | Loggia Nicoletta |
Director | Award | 14,240 |
| 2025-06-17 | PAPA JOSEPH C |
Director, President and CEO | Award | 14,240 |
| 2025-06-17 | Martell Christopher |
Director | Award | 14,240 |
| 2025-06-17 | Manning Paul B |
10% Owner | Award | 14,240 |
| 2025-06-17 | Nabel Gary J. |
Director, Chief Innovation Officer | Award | 14,240 |
| 2025-06-17 | Nguyen Diem |
Director | Award | 14,240 |
| 2025-06-04 | Radhakrishnan Maha |
Director | Other | 0 |
| 2025-06-04 | Radhakrishnan Maha |
Director | Award | 28,480 |
| 2025-03-19 | Tak Paul Peter |
Director, Chief Executive Officer | Sell | 400 |
| 2025-03-18 | Nichols William Garrett |
Chief Medical Officer | Convert | 13,905 |
| 2025-03-18 | Nichols William Garrett |
Chief Medical Officer | Convert | 4,584 |
| 2025-03-18 | Tak Paul Peter |
Director, Chief Executive Officer | Sell | 25,772 |
| 2025-03-18 | Nichols William Garrett |
Chief Medical Officer | Convert | 13,905 |
| 2025-03-18 | Nichols William Garrett |
Chief Medical Officer | Sell | 45,316 |
| 2025-03-18 | Barone Francesca |
Chief Scientific Officer | Convert | 18,000 |
| 2025-03-18 | Nichols William Garrett |
Chief Medical Officer | Convert | 4,584 |
Showing 1–50 of 321 transactions